Even before it went on the market in 2002, doctors were talking about how the back surgery product known as bone morphogenetic protein-2 would revolutionize medicine.
Fallout from back-surgery product prompting reforms
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.